The intersection of race and opioid use disorder treatment: A quantitative analysis

Racial health inequities exist in the United States. Racial minorities and whites have different health care experiences and health outcomes. Past studies examined this relationship for health care treatment, but additional research on whether and how race affects treatment for opioid use disorder (OUD) is needed. Based on systematic racism theory, this study examines the relationship between race and OUD treatment in three ways, representing three different phases in the treatment process: referral source for treatment, whether the treatment plan includes medications for OUD (MOUD), and reason for discharge.

This study examines the relationship between race and treatment for OUD. The study uses data from the 2013 and 2017 Treatment Episode Data Set Discharges (TEDS-D) dataset to run logistical and multinomial regression models.

This study found that a relationship between race and treatment for OUD exists in all three areas that we examined. Specifically, this study found that being a minority was associated with a decreased likelihood of being referred to treatment by a medical professional, a decreased likelihood of having MOUD as part of the treatment plan (although the opposite was true in 2013), and a decreased likelihood of leaving treatment because the treatment episode was complete.

Policymakers should use these findings to develop policy interventions for OUD that recognize the systematic racism that exists rather than our current colorblind policies.